Literature DB >> 16782887

Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.

Laurens A van Meeteren1, Paula Ruurs, Catelijne Stortelers, Peter Bouwman, Marga A van Rooijen, Jean Philippe Pradère, Trevor R Pettit, Michael J O Wakelam, Jean Sébastien Saulnier-Blache, Christine L Mummery, Wouter H Moolenaar, Jos Jonkers.   

Abstract

Autotaxin (ATX), or nucleotide pyrophosphatase-phosphodiesterase 2, is a secreted lysophospholipase D that promotes cell migration, metastasis, and angiogenesis. ATX generates lysophosphatidic acid (LPA), a lipid mitogen and motility factor that acts on several G protein-coupled receptors. Here we report that ATX-deficient mice die at embryonic day 9.5 (E9.5) with profound vascular defects in yolk sac and embryo resembling the Galpha13 knockout phenotype. Furthermore, at E8.5, ATX-deficient embryos showed allantois malformation, neural tube defects, and asymmetric headfolds. The onset of these abnormalities coincided with increased expression of ATX and LPA receptors in normal embryos. ATX heterozygous mice appear healthy but show half-normal ATX activity and plasma LPA levels. Our results reveal a critical role for ATX in vascular development, indicate that ATX is the major LPA-producing enzyme in vivo, and suggest that the vascular defects in ATX-deficient embryos may be explained by loss of LPA signaling through Galpha13.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782887      PMCID: PMC1489177          DOI: 10.1128/MCB.02419-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Large-scale analysis of the human and mouse transcriptomes.

Authors:  Andrew I Su; Michael P Cooke; Keith A Ching; Yaron Hakak; John R Walker; Tim Wiltshire; Anthony P Orth; Raquel G Vega; Lisa M Sapinoso; Aziz Moqrich; Ardem Patapoutian; Garret M Hampton; Peter G Schultz; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells.

Authors:  S W Nam; T Clair; C K Campo; H Y Lee; L A Liotta; M L Stracke
Journal:  Oncogene       Date:  2000-01-13       Impact factor: 9.867

3.  A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.

Authors:  J S Saulnier-Blache; A Girard; M F Simon; M Lafontan; P Valet
Journal:  J Lipid Res       Date:  2000-12       Impact factor: 5.922

Review 4.  Death before birth: clues from gene knockouts and mutations.

Authors:  A J Copp
Journal:  Trends Genet       Date:  1995-03       Impact factor: 11.639

5.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

Authors:  Y Liu; R Wada; T Yamashita; Y Mi; C X Deng; J P Hobson; H M Rosenfeldt; V E Nava; S S Chae; M J Lee; C H Liu; T Hla; S Spiegel; R L Proia
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

6.  Extracellular matrix molecules regulate endothelial cell migration stimulated by lysophosphatidic acid.

Authors:  T S Panetti; D F Hannah; C Avraamides; J P Gaughan; C Marcinkiewicz; A Huttenlocher; D F Mosher
Journal:  J Thromb Haemost       Date:  2004-09       Impact factor: 5.824

Review 7.  Thrombogenic and atherogenic activities of lysophosphatidic acid.

Authors:  Wolfgang Siess; Gabor Tigyi
Journal:  J Cell Biochem       Date:  2004-08-15       Impact factor: 4.429

Review 8.  The ins and outs of lysophosphatidic acid signaling.

Authors:  Wouter H Moolenaar; Laurens A van Meeteren; Ben N G Giepmans
Journal:  Bioessays       Date:  2004-08       Impact factor: 4.345

9.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

Authors:  M L Stracke; H C Krutzsch; E J Unsworth; A Arestad; V Cioce; E Schiffmann; L A Liotta
Journal:  J Biol Chem       Date:  1992-02-05       Impact factor: 5.157

10.  Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin.

Authors:  E L George; E N Georges-Labouesse; R S Patel-King; H Rayburn; R O Hynes
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  217 in total

1.  Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.

Authors:  Ryota Itoh; Shigenori Miura; Aki Takimoto; Shunya Kondo; Hiroko Sano; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2010-05-11       Impact factor: 2.626

2.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

3.  Ligand-based autotaxin pharmacophore models reflect structure-based docking results.

Authors:  Catrina D Mize; Ashley M Abbott; Samantha B Gacasan; Abby L Parrill; Daniel L Baker
Journal:  J Mol Graph Model       Date:  2011-09-18       Impact factor: 2.518

Review 4.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

5.  Depot-specific regulation of autotaxin with obesity in human adipose tissue.

Authors:  Chloé Rancoule; Rodolphe Dusaulcy; Karine Tréguer; Sandra Grès; Charlotte Guigné; Didier Quilliot; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2012-05-27       Impact factor: 4.158

6.  An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.

Authors:  Flavia V Castelino; Gretchen Bain; Veronica A Pace; Katharine E Black; Leaya George; Clemens K Probst; Lance Goulet; Robert Lafyatis; Andrew M Tager
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

7.  Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.

Authors:  Sue-Chin Lee; Yuko Fujiwara; Jianxiong Liu; Junming Yue; Yoshibumi Shimizu; Derek D Norman; Yaohong Wang; Ryoko Tsukahara; Erzsebet Szabo; Renukadevi Patil; Souvik Banerjee; Duane D Miller; Louisa Balazs; Manik C Ghosh; Christopher M Waters; Tamas Oravecz; Gabor J Tigyi
Journal:  Mol Cancer Res       Date:  2014-08-26       Impact factor: 5.852

Review 8.  Lysophospholipids in coronary artery and chronic ischemic heart disease.

Authors:  Ahmed Abdel-Latif; Paula M Heron; Andrew J Morris; Susan S Smyth
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

9.  Lysophosphatidic acid produced by hen egg white lysophospholipase D induces vascular development on extraembryonic membranes.

Authors:  Junichi Morishige; Yoshihiro Uto; Hitoshi Hori; Kiyoshi Satouchi; Tanihiro Yoshiomoto; Akira Tokumura
Journal:  Lipids       Date:  2013-02-06       Impact factor: 1.880

10.  Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.

Authors:  Tae Nakasaki; Toshiyuki Tanaka; Shinichi Okudaira; Michi Hirosawa; Eiji Umemoto; Kazuhiro Otani; Soojung Jin; Zhongbin Bai; Haruko Hayasaka; Yoshinori Fukui; Katsuyuki Aozasa; Naoya Fujita; Takashi Tsuruo; Keiichi Ozono; Junken Aoki; Masayuki Miyasaka
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.